Haemonetics Corp (NYSE:HAE)

89.53
Delayed Data
As of Sep 29
 -0.05 / -0.06%
Today’s Change
72.26
Today|||52-Week Range
95.26
+13.83%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$4.5B

Company Description

Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, Hospital, and Corporate. The Plasma segment offers automated plasma collection and donor management software systems. The Blood Center segment provides solutions for donor collection centers' ability to acquire blood, filter blood, and separate blood components. The Hospital segment includes hemostasis management, cell salvage, and transfusion management services that help decision makers in hospitals optimize blood acquisition, storage, and usage in critical settings. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Boston, MA.

Contact Information

Haemonetics Corp.
125 Summer Street
Boston Massachusetts 02110
P:(781) 848-7100
Investor Relations:
(718) 356-9763

Employees

Shareholders

Mutual fund holders69.15%
Other institutional32.12%
Individual stakeholders3.29%

Top Executives

Christopher A. SimonPresident, Chief Executive Officer & Director
James C. D'AreccaChief Financial Officer & Executive Vice President
Jan HartmannSenior Vice President & Chief Medical Officer
Anila LingamneniChief Technology Officer & Executive VP
Laurie A. MillerChief Human Resources Officer & Senior VP